CBER

stack of letters mail envelopes
Marketing

FDA targets Big Pharma in deluge of marketing letters

After the FDA announced it was cracking down on what it has determined to be “misleading” or “deceptive” DTC drug ads, the floodgates have opened.
Andrea Park Sep 16, 2025 1:55pm
AstraZeneca FluMist Home ad

AstraZeneca TV spot for at-home FluMist lands in FDA crosshairs

Sep 16, 2025 11:07am
FDA

Vinay Prasad is back at the FDA after last month's surprise ouster

Aug 9, 2025 12:22pm
Graphic of a fork in the road with arrows pointing in either direction

Prasad exit signals more permissive FDA for cell and gene field

Jul 31, 2025 9:10am
target reach ladder climb meet win beat competition

FDA taps new CDER chief as acting CBER head after Prasad exit

Jul 30, 2025 1:10pm
FDA

FDA investigates 2 deaths after Sarepta Duchenne gene therapy

Jun 25, 2025 10:26am